TrialEuropean journal of endocrinology2022

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Rasmus Juul Kildemoes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.